ARCHIVES

FDA Approves New Indication For Anticoagulant Frangmin

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

No Cancer Letter For Next Two Weeks

August 19, 1994

PCORI Approves $54.8 Million For Clinical Effectiveness Research

August 1, 2014

For A Better View Of Molecular Targets, NCI Project To Draw Pictures Of Cancers.

June 15, 2001

Decision To Stop NSABP P-4 Study Before It Starts Shocks Clinical Trialists.

March 2, 2007

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials

March 26, 2004